InsiderTrades.com logo
Have You Seen Elon’s New A.I. Device? (Picture Inside)
From InvestorPlace   |   Ad
A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...
This strange new device to protect us against that A.I. threat...

CGON Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $12,662,968.00
Insider Selling (Last 12 Months): $0.00

CG Oncology Insider Trading History Chart

This chart shows the insider buying and selling history at CG Oncology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CG Oncology Share Price & Price History

Current Price: $41.93
Price Change: ▲ Price Increase of +1.31 (3.23%)
As of 05/2/2024 12:21 PM ET

This chart shows the closing price history over time for CGON up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The biggest energy story ever?
From Porter & Company   |   Ad
Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…
For the full story, click here.

CG Oncology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2024Corleen M RocheCFOBuy2,000$19.00$38,000.002,000View SEC Filing Icon  
1/29/2024Decheng Capital Global Life ScMajor ShareholderBuy400,000$19.00$7,600,000.00400,000View SEC Filing Icon  
1/29/2024Hong Fang SongDirectorBuy263,157$19.00$4,999,983.00613,928View SEC Filing Icon  
1/29/2024Vijay KasturiInsiderBuy1,315$19.00$24,985.001,315View SEC Filing Icon  
See Full Table
The biggest energy story ever?
From Porter & Company   |   Ad
Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…
For the full story, click here.

SEC Filings (Institutional Ownership Changes) for CG Oncology (NASDAQ:CGON)

26.56% of CG Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

CG Oncology Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/1/2024Capstone Investment Advisors LLC18,354$0.81M0.0%N/A0.028%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets11,198$0.49M0.0%N/A0.017%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CG Oncology logo
CG Oncology, Inc., an oncolytic immunotherapy company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients. It also develops PIVOT-006, a cretostimogene monotherapy for intermediate-risk NMIBC following transurethral resection of the bladder tumor; and CORE-008 for treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC patients. CG Oncology, Inc. was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. The company was founded in 2010 and is based in Irvine, California.
Read More on CG Oncology

Today's Range

Now: $41.93
Low: $38.93
High: $42.28

50 Day Range

MA: $39.91
Low: $33.54
High: $46.35

52 Week Range

Now: $41.93
Low: $28.55
High: $50.23

Volume

89,915 shs

Average Volume

607,572 shs

Market Capitalization

$2.79 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of CG Oncology?

CG Oncology's top insider investors include:
  1. Hong Fang Song (Director)
  2. Decheng Capital Global Life Sc (Major Shareholder)
  3. Corleen M Roche (CFO)
  4. Vijay Kasturi (Insider)
Learn More about top insider investors at CG Oncology.

Who are the major institutional investors of CG Oncology?

CG Oncology's top institutional shareholders include:
  1. Capstone Investment Advisors LLC — 0.03%
  2. BNP Paribas Financial Markets — 0.02%
  3. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of CG Oncology stock.

Which institutional investors are buying CG Oncology stock?

Within the last quarter, CGON stock was bought by institutional investors including:
  1. Capstone Investment Advisors LLC
  2. BNP Paribas Financial Markets
In the last year, these company insiders have bought CG Oncology stock:
  1. Hong Fang Song (Director)
  2. Decheng Capital Global Life Sc (Major Shareholder)
  3. Corleen M Roche (CFO)
  4. Vijay Kasturi (Insider)
Learn More investors buying CG Oncology stock.
Have You Seen Elon’s New A.I. Device? (Picture Inside)
From InvestorPlace   |   Ad
A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...
This strange new device to protect us against that A.I. threat...